INDP
Indaptus Therapeutics, Inc.
Key Financials
Operating Income
$-19833513
↓ 29.1%
Net Income
$-20848916
↓ 38.8%
Shareholders' Equity
$3.2M
↓ 20.1%
EPS (Diluted)
$-21.58
↓ 1240.4%
Total Liabilities
$3.4M
↑ 19.2%
Total Assets
$9.3M
↑ 26.9%
Cash & Equivalents
$8.5M
↑ 47.0%
Operating Cash Flow
$-14823256.00
↓ 20.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/30/2026 | View on SEC |
| 8-K | 9/10/2026 | View on SEC |
| 8-K/A | 9/8/2026 | View on SEC |
| 8-K | 9/4/2026 | View on SEC |
| 424B5 | 9/4/2026 | View on SEC |
| 8-K | 9/1/2026 | View on SEC |
| 424B5 | 8/31/2026 | View on SEC |
| 424B3 | 8/26/2026 | View on SEC |
| EFFECT | 8/25/2026 | View on SEC |
| S-3 | 8/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INDP |
| Company Name | Indaptus Therapeutics, Inc. |
| CIK | 1857044 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (646) 427-2727 |